UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Open‐Label Discontinuation Trial of Long‐Term, Off‐Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure

Journal of clinical pharmacology, 2018-11, Vol.58 (11), p.1418-1426

2018

Volltextzugriff (PDF)

A survey on service users' perspectives about information and shared decision‐making in psychotropic drug prescriptions in people with intellectual disabilities

British journal of learning disabilities, 2024-06, Vol.52 (2), p.350-361

2024

Volltextzugriff (PDF)

An Open Label Discontinuation Trial of Long-Term Used Off-Label Antipsychotic Drugs in People with Intellectual Disability: The Influence of Staff-Related Factors

Journal of applied research in intellectual disabilities, 2019-03, Vol.32 (2), p.313-322

2019

Volltextzugriff (PDF)

Changes in Health‐Related Quality of Life in People With Intellectual Disabilities Who Discontinue Long‐Term Used Antipsychotic Drugs for Challenging Behaviors

Journal of clinical pharmacology, 2019-02, Vol.59 (2), p.280-287

2019

Volltextzugriff (PDF)

Effects of positive behaviour support delivered by direct staff on challenging behaviours and quality of life of adults with intellectual disabilities: A multicentre cluster‐controlled trial

Journal of applied research in intellectual disabilities, 2024-01, Vol.37 (1), p.e13164-n/a

2024

Volltextzugriff (PDF)

Preferred outcome measures in treatments for challenging behaviour in individuals with intellectual disabilities: Results of an inclusive Delphi method

Journal of applied research in intellectual disabilities, 2023-03, Vol.36 (2), p.374-384

2023

Volltextzugriff (PDF)

Exploring the association of staff characteristics with staff perceptions of quality of life of individuals with intellectual disabilities and challenging behaviours

Journal of applied research in intellectual disabilities, 2022-09, Vol.35 (5), p.1231-1243

2022

Volltextzugriff (PDF)

Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales

Journal of clinical psychopharmacology, 2016-10, Vol.36 (5), p.508-512

2016

Volltextzugriff (PDF)

First Steps Toward Positive Behavior Support in the Netherlands: A Pilot Study Exploring the Effectiveness of a Training for Staff

Journal of policy and practice in intellectual disabilities, 2020-09, Vol.17 (3), p.188-194

2020

Volltextzugriff (PDF)

Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics

Research in developmental disabilities, 2013-09, Vol.34 (9), p.2799-2809

2013

Volltextzugriff (PDF)

Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities

Journal of applied research in intellectual disabilities, 2017-12, Vol.30 (S1), p.1-9

2017

Volltextzugriff (PDF)

Adherence of clinicians to guidelines for the prescription of antipsychotic drugs to people with intellectual disabilities

Advances in mental health and intellectual disabilities, 2017-05, Vol.11 (3), p.110-125

2017

Volltextzugriff (PDF)

Effects of discontinuation of long-term used antipsychotics on prolactin and bone turnover markers in patients with intellectual disability

Journal of clinical psychopharmacology, 2014-02, Vol.34 (1), p.157-159

2014

Volltextzugriff (PDF)

Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities

Research in developmental disabilities, 2024-10, Vol.153, p.104824, Article 104824

2024

Volltextzugriff (PDF)

Staff ability to carry out behavioural strategies for individuals with intellectual disabilities and challenging behaviours

Advances in mental health and intellectual disabilities, 2016-07, Vol.10 (4), p.248-257

2016

Volltextzugriff (PDF)

Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial

International journal of environmental research and public health, 2024-07, Vol.21 (7), p.950

2024

Volltextzugriff (PDF)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience

International journal of environmental research and public health, 2022-11, Vol.19 (23), p.15637

2022

Volltextzugriff (PDF)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers

International journal of environmental research and public health, 2022-12, Vol.19 (24), p.17095

2022

Volltextzugriff (PDF)

Difficulties in Addressing Diagnostic, Treatment and Support Needs in Individuals with Intellectual Disability and Persistent Challenging Behaviours: A Descriptive File Study of Referrals to an Expertise Centre

International journal of environmental research and public health, 2023-07, Vol.20 (14), p.6365

2023

Volltextzugriff (PDF)

Health-related quality of life in people with intellectual disability who use long-term antipsychotic drugs for challenging behaviour

Research in developmental disabilities, 2018-04, Vol.75, p.49-58

2018

Volltextzugriff (PDF)

Exploring barriers and facilitators in the implementation and use of guideline recommendations on antipsychotic drug prescriptions for people with intellectual disability

Journal of applied research in intellectual disabilities, 2018-11, Vol.31 (6), p.1062-1070

2018

Volltextzugriff (PDF)

Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription

Journal of intellectual disability research, 2010-07, Vol.54 (7), p.659-667

2010

Volltextzugriff (PDF)

Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability

Journal of clinical psychopharmacology, 2013-08, Vol.33 (4), p.520-524

2013

Volltextzugriff (PDF)

Is risperidon bij probleemgedrag effectief?

Kind en adolescent praktijk, 2018-03, Vol.17 (1), p.38-41

2018

Volltextzugriff (PDF)

Functional Analysis of Novel Genetic Variation in the Thyroid Hormone Activating Type 2 Deiodinase

The journal of clinical endocrinology and metabolism, 2014-11, Vol.99 (11), p.E2429-E2436

2014

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(26)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Intellectual Disabilities
(17)
Intellectual Disability
(15)
Humans
(14)
Psychotropic Drugs
(12)
Rehabilitation
(11)
Social Sciences
(11)
Antipsychotics
(10)
Adult
(9)
Intellectual Disability - Drug Therapy
(9)
Female
(8)
Male
(8)
Middle Aged
(8)
Quality Of Life
(8)
Antipsychotic Drugs
(7)
Behavior Disorders
(7)
Behavior Problems
(7)
Psychology
(7)
Antipsychotic Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An Open‐Label Discontinuation Trial of Long‐Term, Off‐Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure

A survey on service users' perspectives about information and shared decision‐making in psychotropic drug prescriptions in people with intellectual disabilities

An Open Label Discontinuation Trial of Long-Term Used Off-Label Antipsychotic Drugs in People with Intellectual Disability: The Influence of Staff-Related Factors

Changes in Health‐Related Quality of Life in People With Intellectual Disabilities Who Discontinue Long‐Term Used Antipsychotic Drugs for Challenging Behaviors

Effects of positive behaviour support delivered by direct staff on challenging behaviours and quality of life of adults with intellectual disabilities: A multicentre cluster‐controlled trial

Preferred outcome measures in treatments for challenging behaviour in individuals with intellectual disabilities: Results of an inclusive Delphi method

Exploring the association of staff characteristics with staff perceptions of quality of life of individuals with intellectual disabilities and challenging behaviours

Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales

First Steps Toward Positive Behavior Support in the Netherlands: A Pilot Study Exploring the Effectiveness of a Training for Staff

Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics

Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities

Adherence of clinicians to guidelines for the prescription of antipsychotic drugs to people with intellectual disabilities

Effects of discontinuation of long-term used antipsychotics on prolactin and bone turnover markers in patients with intellectual disability

Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities

Staff ability to carry out behavioural strategies for individuals with intellectual disabilities and challenging behaviours

Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers

Difficulties in Addressing Diagnostic, Treatment and Support Needs in Individuals with Intellectual Disability and Persistent Challenging Behaviours: A Descriptive File Study of Referrals to an Expertise Centre

Health-related quality of life in people with intellectual disability who use long-term antipsychotic drugs for challenging behaviour

Exploring barriers and facilitators in the implementation and use of guideline recommendations on antipsychotic drug prescriptions for people with intellectual disability

Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription

Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability

Is risperidon bij probleemgedrag effectief?

Functional Analysis of Novel Genetic Variation in the Thyroid Hormone Activating Type 2 Deiodinase

Suchergebnisse filtern